EXPORT CITATION

Chapter-169 Intravenous Cyclophosphamide versus Rituximab for the Treatment of Early Diffuse Scleroderma Lung Disease: Open Label, Randomized, Controlled Trial

BOOK TITLE: Year Book of Medicine 2019

Author
1. Handa Rohini
2. Sharma Aman
3. Misra Durga Prasanna
ISBN
9789389188738
DOI
10.5005/jp/books/18366_171
Edition
1/e
Publishing Year
2019
Pages
1
Author Affiliations
1. Apollo Indraprastha Hospital, New Delhi, India, All India Institute of Medical Sciences, New Delhi, Apollo Indraprastha Hospitals, New Delhi, India, Indraprastha Apollo Hospitals, New Delhi, India
2. Postgraduate Institute of Medical Education and Research, Chandigarh, India, Apollo Hospital, Bilaspur, Chhattisgarh, India, PGIMER, Chandigarh, India, New Cross Hospital, Wolverhampton, United Kingdom, Post Graduate Institute of Medical Education and Research, Chandigarh, India, Postgraduate Institute of Medical, Education and Research (PGIMER), Chandigarh, India
3. Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, SGPGI, Lucknow, Uttar Pradesh, India
Chapter keywords
Intravenous cyclophosphamide, rituximab, treatment, scleroderma lung disease, open label trial, interstitial lung disease, skin manifestation, echocardiographic criteria, B lymphocyte, forced vital capacity, FVC

Abstract

Related Books

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved